Analyst Price Targets — LMAT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 10, 2025 2:16 pm | Ross Osborn | Cantor Fitzgerald | $95.00 | $86.96 | StreetInsider | Cantor Fitzgerald Reiterates Neutral Rating on LeMaitre Vascular (LMAT) |
| November 5, 2025 9:22 am | — | Roth Capital | $108.00 | $87.26 | TheFly | LeMaitre resumed with a Buy at Roth Capital |
| February 28, 2025 1:53 pm | — | Lake Street | $110.00 | $91.85 | TheFly | LeMaitre price target raised to $110 from $105 at Lake Street |
| October 15, 2024 6:11 am | Ross Osborn | Cantor Fitzgerald | $96.00 | $92.14 | TheFly | LeMaitre initiated with a Neutral at Cantor Fitzgerald |
| August 20, 2024 5:54 am | Daniel Stauder | JMP Securities | $100.00 | $85.53 | TheFly | LeMaitre price target raised to $100 from $77 at JMP Securities |
| April 26, 2024 3:03 am | Rick Wise | Stifel Nicolaus | $75.00 | $65.46 | StreetInsider | Stifel Upgrades LeMaitre Vascular (LMAT) to Buy |
| September 6, 2023 3:04 pm | Suraj Kalia | Oppenheimer | $70.00 | $56.71 | Benzinga | Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating |
Latest News for LMAT
LeMaitre Vascular delivered strong Q4 and FY 2025 results, with 16% YoY sales growth and broad-based margin expansion. Artegraft's international rollout exceeded expectations, with 2025 sales doubling guidance and a projected $10M in 2026. This could drive earnings growth for years to come. LMAT maintains a robust $190M net cash position and recently increased its dividend by 25%. The board has also authorized a…
BURLINGTON, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in five upcoming investor conferences in March.
LeMaitre Vascular, Inc. (LMAT) Q4 2025 Earnings Call Transcript
BURLINGTON, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q4 2025 results, announced a quarterly dividend of $0.25/share (+25%), and provided guidance.
Public Sector Pension Investment Board raised its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) by 15.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,211 shares of the medical instruments supplier's stock after acquiring an additional 11,092 shares
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LMAT.
U.S. House Trading
No House trades found for LMAT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.